(Q42435905)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23508306%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

title

Lysophosphatidic acid impairs glucose homeostasis and inhibits insulin secretion in high-fat diet obese mice (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23508306%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

0 references

1 reference

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23508306%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

author name string

C Rancoule

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23508306%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

C Attané

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23508306%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

S Grès

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23508306%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

A Fournel

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23508306%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

R Dusaulcy

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23508306%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

C Bertrand

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23508306%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

C Vinel

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23508306%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

K Tréguer

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23508306%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

M Prentki

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23508306%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

J S Saulnier-Blache

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23508306%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

publication date

19 March 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23508306%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23508306%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

volume

56

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23508306%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23508306%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

page(s)

1394-1402

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23508306%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00125-013-2891-3

26 February 2020

exact match

0 references

cites work

Adipose tissue remodeling in pathophysiology of obesity

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2891-3

Impact of increased adipose tissue mass on inflammation, insulin resistance, and dyslipidemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2891-3

The autocrine and paracrine roles of adipokines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2891-3

LPA receptors: subtypes and biological actions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2891-3

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2891-3

Autotaxin--an LPA producing enzyme with diverse functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2891-3

LPA and its analogs-attractive tools for elucidation of LPA biology and drug development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2891-3

Pharmacological tools for lysophospholipid GPCRs: development of agonists and antagonists for LPA and S1P receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2891-3

Lysophosphatidic acid-1-receptor targeting agents for fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2891-3

Ki16425, a Subtype-Selective Antagonist for EDG-Family Lysophosphatidic Acid Receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2891-3

The type 1 lysophosphatidic acid receptor is a target for therapy in bone metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2891-3

LPA1 receptor activation promotes renal interstitial fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2891-3

Alpha2-adrenergic receptor-mediated release of lysophosphatidic acid by adipocytes. A paracrine signal for preadipocyte growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2891-3

Autotaxin is released from adipocytes, catalyzes lysophosphatidic acid synthesis, and activates preadipocyte proliferation. Up-regulated expression with adipocyte differentiation and obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2891-3

Potential involvement of adipocyte insulin resistance in obesity-associated up-regulation of adipocyte lysophospholipase D/autotaxin expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2891-3

Adipose-specific disruption of autotaxin enhances nutritional fattening and reduces plasma lysophosphatidic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2891-3

Lysophosphatidic acid inhibits adipocyte differentiation via lysophosphatidic acid 1 receptor-dependent down-regulation of peroxisome proliferator-activated receptor gamma2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2891-3

LPA is a novel lipid regulator of mesangial cell hexokinase activity and HKII isoform expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2891-3

Lysophosphatidic acid regulates blood glucose by stimulating myotube and adipocyte glucose uptake

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2891-3

Itch-scratch responses induced by lysophosphatidic acid in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2891-3

Lysophosphatidic acid receptors LPA1 and LPA3 promote CXCL12-mediated smooth muscle progenitor cell recruitment in neointima formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2891-3

CD36-dependent regulation of muscle FoxO1 and PDK4 in the PPAR delta/beta-mediated adaptation to metabolic stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2891-3

Apelin stimulates glucose utilization in normal and obese insulin-resistant mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2891-3

Adipose triglyceride lipase is implicated in fuel- and non-fuel-stimulated insulin secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2891-3

Lysophosphatidic acid (LPA) receptors are activated differentially by biological fluids: possible role of LPA-binding proteins in activation of LPA receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2891-3

Type 2 diabetes across generations: from pathophysiology to prevention and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2891-3

Lysophosphatidylinositol, but not lysophosphatidic acid, stimulates insulin release. A possible role for phospholipase A2 but not de novo synthesis of lysophospholipid in pancreatic islet function

21 January 2018

1 reference

12 December 2020

Lipoprotein-Derived Lysophosphatidic Acid Promotes Atherosclerosis by Releasing CXCL1 from the Endothelium

1 reference

12 December 2020

Lysophosphatidic acid inhibits bacterial endotoxin-induced pro-inflammatory response: potential anti-inflammatory signaling pathways

1 reference

12 December 2020

Lysophosphatidic acid decreases glutamate and glucose uptake by astrocytes.

1 reference

12 December 2020

A simple and highly sensitive radioenzymatic assay for lysophosphatidic acid quantification.

1 reference

12 December 2020

Depot-specific regulation of autotaxin with obesity in human adipose tissue

1 reference

12 December 2020

Secretion of a lysophospholipase D activity by adipocytes: involvement in lysophosphatidic acid synthesis

1 reference

12 December 2020